NIH CFAR Administrative Supplements
2022 Awards
CytoFLEX S Flow Analyzer to characterize HIV-1 infected and cART-affected cells
Sergei Nekhai, PhD (HU) has received an NIH CFAR Administrative Supplement entitled, “CytoFLEX S Flow Analyzer to characterize HIV-1 infected and cART-affected cells”.
Development of an HIV Status-Neutral Video Intervention to Reduce Stigma and Promote U=U and PrEP Among Sexual and Gender Minority DC Community Members
Sarah Calabrese, PhD (GW) has received an NIH CFAR Administrative Supplement entitled, “Development of an HIV Status-Neutral Video Intervention to Reduce Stigma and Promote U=U and PrEP Among Sexual and Gender Minority DC Community Members.”
Development of a Community-based HIV Pre-Exposure Prophylaxis Service Delivery Intervention for Black Adults in the District of Columbia
Donaldson Conserve, MS, PhD (GW) has received an NIH CFAR Administrative Supplement entitled, “Development of a Community-based HIV Pre-Exposure Prophylaxis Service Delivery Intervention for Black Adults in the District of Columbia”.
Accelerating collaboration and opportunities for scale up to end the HIV epidemic for Latinas/os/xs in the Mid-Atlantic region
Nina Yamanis, PhD (AU) has received an NIH CFAR Administrative Supplement entitled, “Accelerating collaboration and opportunities for scale up to end the HIV epidemic for Latinas/os/xs in the Mid-Atlantic region”.
Using a positive deviance approach for PrEP implementation among Latino populations in Puerto Rico and Washington, DC
Carlos E. Rodríguez-Díaz, PhD, MPHE, MCHES (GW) has received an NIH CFAR Administrative Supplement entitled, “Using a positive deviance approach for PrEP implementation among Latino populations in Puerto Rico and Washington, DC”.2021 Awards
Improving Potentially Inappropriate Prescribing (PIP) for Aging People with HIV: An Individualized Approach to be Scaled City-Wide
Anne Monroe, MD, MSPH (GW) has received an NIH CFAR Administrative Supplement entitled, “Improving Potentially Inappropriate Prescribing (PIP) for Aging People with HIV: An Individualized Approach to be Scaled City-Wide”.
Implementing Brain Health Assessment into the HIV Care Continuum in Washington DC
Marjorie Gondré-Lewis, PhD (HU) has received an NIH CFAR Administrative Supplement entitled, “Implementing Brain Health Assessment into the HIV Care Continuum in Washington DC”.
Addressing Intersectional and Social-Structural Barriers to Ending the HIV Epidemic in Black Sexual Minority Men and Black Heterosexual Women
Lisa Bowleg, PhD, MA (GW) has received an NIH CFAR Administrative Supplement entitled, “Addressing Intersectional and Social-Structural Barriers to Ending the HIV Epidemic in Black Sexual Minority Men and Black Heterosexual Women”.
Automated Cell Isolation using the RoboSepTM System and Muse Cell Analyzer for HIV Cure Studies
Natalia Soriano-Sarabia, PhD (GW) has received an NIH CFAR Administrative Supplement entitled, “Automated Cell Isolation using the RoboSepTM System and Muse Cell Analyzer for HIV Cure Studies”. An intersectionality-based policy analysis of social determinants of HIV in Puerto Rico
Carlos Rodriguez-Diaz, PhD, MPHE, MCHES (GW) has received an NIH CFAR Administrative Supplement entitled, “An intersectionality-based policy analysis of social determinants of HIV in Puerto Rico”.2019 Awards
A City-Wide Approach to HIV Pre-Exposure Prophylaxis (PrEP) Scale-Up in Multiple High-Risk Communities in Washington D.C.
Sarah Henn, MD, MPH (Whitman-Walker Health) has been awarded an NIH CFAR Administrative supplement titled, “A City-Wide Approach to HIV Pre-Exposure Prophylaxis (PrEP) Scale-Up in Multiple High-Risk Communities in Washington D.C.” This project will address the “Prevent” pillar of the nationwide Ending the HIV (EHE) initiative.The Development of Responsive Health Department HIV Data to Action Strategies through Community Engagement
Adam Allston, PhD, MPH, MSW and Brittani Saafir Callaway, PhD, MPH (DC Health) have been awarded a NIH CFAR Administrative Supplement titled, “The Development of Responsive Health Department HIV Data to Action Strategies through Community Engagement.”
Citywide Expansion of Rapid Antiretroviral Therapy Initiation in the District of Columbia
Rupali Doshi, MD, MS (DC Health) has received an NIH CFAR Administrative Supplement entitled, “Citywide Expansion of Rapid Antiretroviral Therapy Initiation in the District of Columbia.
Puerto Rico-DC CFAR government-community-academic partnership (GCAP) for comprehensive HIV prevention and response
Carlos Rodriguez-Diaz, PhD, MPHE, MCHES (GW) has received an NIH CFAR Administrative Supplement entitled, “Puerto Rico-DC CFAR government-community-academic partnership (GCAP) for comprehensive HIV prevention and response”.2018 Awards
Implications of time to ART for antibody-based cure strategies
Rebecca Lynch, PhD, has received an NIH CFAR Administrative Supplement entitled, "Implications of time to ART for antibody-based cure strategies" to study methods to restrict and/or clear persistent viral reservoirs for individuals treated using antiretroviral therapy (ART).2016 Awards
Real-time Phylodynamic Analysis of HIV in Washington, DC
Amanda Castel, MD, MPH, and Marcos Perez-Losada, PhD, MS have received an NIH CFAR Administrative Supplement to study HIV transmission patterns in Washington, DC to better identify which subpopulations and geographic areas are at highest risk for transmission and potential spread.2015 Awards
Impairment of ABCA1 glycosylation as a pathogenic mechanism in Nef-induced atherosclerosis
Radoslav Goldman, PhD has received an NIH CFAR Administrative supplement to characterize the role of glycosylation in ABCA1 functionality. ABCA1 is a key anti-atherogenic factor responsible for HDL production and cholesterol efflux. ABCA1 is targeted by HIV-1 Nef, which impairs ABCA1 maturation. Maturation of ABCA1 is tightly linked to its glycosylation, but detailed characterization of the role of glycosylation in ABCA1 functionality has not been done. Dr. Radoslav seeks to close this gap in our knowledge, providing the basis for future therapeutic efforts.Advancing Pre-exposure Prophylaxis (PrEP) Delivery among Black MSM in the District of Columbia
Marc Siegel, MD has received an NIH CFAR Administrative supplement to study whether a novel culturally competent clinic intervention can increase the uptake of pre-exposure prophylaxis (PrEP) to prevent HIV infection in black and young men who have sex with men. This population are among the only US populations to have recently experienced a significant increase in the number of incident HIV infections.
